BrodersA. C.: Epithelioma of genitourinary organs. Ann. Surg. 76; 574–584 (1923).
2.
BruceA. W., O'CleirachaimF., MoralesA., AwardS.: Carcinoma of the prostate: A critical look at staging. J. Urol., 117; 319–321 (1977).
3.
ChoeB. K., PontesE. J., McDonaldI., RoseR.: Immunochemical studies of prostatic acid phosphatase. Cancer Treat. Rep., 61; 201–204 (1977).
4.
FotiA. G., CooperJ. F., HerschmanH., MalvaezR. R.: Detection of prostatic cancer by solid phase radioimmunoassay of serum prostatic phosphatase. N. Engl. J. Med., 297; 1357–1361 (1977).
5.
FotiA. G., HerschmanH., CooperJ. F.: Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay. Clin. Chem., 23; 95–99 (1977).
6.
HugginsC., HodgesC. V.: Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1; 293–297 (1941).
7.
IshibeT., UsuiT., NihiraH.: Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate. J. Urol., 112; 237–240 (1974).
8.
KingE. J., ArmstrongA. R.: A convenient method for determining serum and bile phosphatase activity. Canad. Med. Ass. J., 31; 376–381 (1934).
9.
MoncureC. W., ProutG. R.jr.: Antigenicitiy of human prostatic acid phosphatase. Cancer, 25; 463–467 (1970).
10.
MurphyG. P., ReynosoG., KennyG. M., GaetaI. F.: Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma. Cancer, 23; 1309–1314 (1969).
11.
RIA Quant-P.A.P. Test: Mallincrodt Nuclear, Inc., St Louis, U.S.A.1979.
12.
TannenbaumM.: Histopathology of the prostate gland. In: TannenbaumM., Urologic pathology: The prostate. Lea & Febiger, p. 303–397, Philadelphia1977.
13.
VihkoP., SajantiE., JähneO., PeltonenL., VihkoR.: Serum prostate-specific acid phosphatase: Development and validation of a specific radioimmunoassay. Clin. Chem., 24; 1915–1919 (1978).
